Amrutanjan Health Care Limited has reported Standalone financial results for the period ended March 31, 2025.
Financial Results (Q4 FY2025) - QoQ Comparison
The company has reported total income of Rs. 140.2329 crores during the period ended March 31, 2025 as compared to Rs. 127.7118 crores during the period ended December 31, 2024.
The company has posted net profit / (loss) of Rs. 15.1778 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs. 19.2457 crores for the period ended December 31, 2024.
The company has reported EPS of Rs. 5.25 for the period ended March 31, 2025 as compared to Rs. 6.66 for the period ended December 31, 2024.
Total Income | ₹ 140.2329 crs | ₹127.7118 crs | 9.80% |
Net Profit | ₹15.1778 crs | ₹19.2457 crs | -21.14% |
EPS | ₹5.25 | ₹6.66 | -21.17% |
Financial Results (Q4 FY2025) - YoY Comparison The company has reported total income of Rs. 140.2329 crores during the period ended March 31, 2025 as compared to Rs.132.0128 crores during the period ended March 31, 2024.
The company has posted net profit / (loss) of Rs.15.1778 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs.13.6590 crores for the period ended March 31, 2024.
The company has reported EPS of Rs.5.25 for the period ended March 31, 2025 as compared to Rs.4.72 for the period ended March 31, 2024.
Total Income | ₹ 140.2329 crs | ₹132.0128 crs | 6.23% |
Net Profit | ₹15.1778 crs | ₹13.6590 crs | 11.12% |
EPS | ₹5.25 | ₹4.72 | 11.23% |
Financial Results (Year Ended FY2025) - YoY Comparison The company has reported total income of Rs.469.4950 crores during the Financial Year ended March 31, 2025 as compared to Rs.437.5788 crores during the Financial Year ended March 31, 2024.
The company has posted net profit / (loss) of Rs.50.8347 crores for the Financial Year ended March 31, 2025 as against net profit / (loss) of Rs.44.9726 crores for the Financial Year ended March 31, 2024.
The company has reported EPS of Rs.17.58 for the Financial Year ended March 31, 2025 as compared to Rs.15.50 for the Financial Year ended March 31, 2024.
Total Income | ₹469.4950 crs | ₹437.5788 crs | 7.29% |
Net Profit | ₹50.8347 crs | ₹44.9726 crs | 13.03% |
EPS | ₹17.58 | ₹15.50 | 13.42% |
Shares of Amrutanjan Health Care Limited was last trading in BSE at Rs. 717.35 as compared to the previous close of Rs. 716.45. The total number of shares traded during the day was 2271 in over 319 trades.
The stock hit an intraday high of Rs. 723.45 and intraday low of 713.10. The net turnover during the day was Rs. 1634444.00.
Source : Equity Bulls
Keywords
AmrutanjanHealthCare
Q4FY25
Q4FY2025
FY2025
ResultUpdate